McKesson (NYSE:MCK), founded in 1833 as John McKesson & Co., is one of the oldest and largest healthcare services and information technology companies in the United States. Headquartered in Irving, Texas, McKesson began as a regional pharmaceutical wholesaler in New York City and over nearly two centuries has grown into a global enterprise serving multiple facets of the healthcare industry.
At the core of McKesson’s operations is its Pharmaceutical Distribution segment, which supplies branded, generic and over-the-counter medications, vaccines and biopharmaceutical therapies to retail pharmacies, hospitals, physician offices and alternate-site care providers. The company also distributes medical-surgical supplies, laboratory products and a broad portfolio of infusion services and equipment, helping to streamline the supply chain and reduce costs for its customers.
Complementing distribution is McKesson’s Technology Solutions segment, offering software and automation solutions designed to improve clinical workflow, enhance care coordination and support revenue management. These technologies include pharmacy automation, electronic health record (EHR) systems, medication management software and analytics platforms. McKesson’s services extend to specialty practices, oncology providers, home health agencies and long-term care facilities.
With operations spanning North America, Europe and select international markets, McKesson serves a diverse customer base that ranges from independent community pharmacies to large health systems. Under the leadership of President and Chief Executive Officer Brian S. Tyler, the company continues to pursue strategic partnerships and acquisitions aimed at expanding its distribution footprint, enhancing its technology offerings and ultimately supporting more efficient, patient-centered care worldwide.
